MMWR Morb Mortal Wkly Rep. 2016 Nov 18;65(45):1276-1277. doi: 10.15585/mmwr.mm6545a7.
Loperamide is an over-the-counter antidiarrheal with opioid-receptor agonist properties. Recommended over-the-counter doses (range = 2-8 mg daily) do not produce opioid effects in the central nervous system because of poor oral bioavailability and P-glycoprotein efflux* of the medication (1); recent reports suggest that large doses (50-300 mg) of loperamide produce euphoria, central nervous system depression, and cardiotoxicity (2-4). Abuse of loperamide for its euphoric effect or for self-treatment of opioid withdrawal is increasing (5). Cases of loperamide abuse reported to the Upstate New York Poison Center and New York City Poison Control Center were analyzed for demographic, exposure, clinical, and laboratory characteristics. Cases of intentional loperamide abuse reported to the National Poison Database System (NPDS) also were analyzed for demographic, dose, formulation, and outcome information.
洛哌丁胺是一种非处方抗腹泻药,具有阿片受体激动剂特性。由于药物的口服生物利用度差和 P 糖蛋白外排*,推荐的非处方剂量(范围为每天 2-8 毫克)不会在中枢神经系统产生阿片样作用(1);最近的报告表明,大剂量(50-300 毫克)的洛哌丁胺会产生欣快感、中枢神经系统抑制和心脏毒性(2-4)。滥用洛哌丁胺以获得欣快感或自行治疗阿片类药物戒断的情况正在增加(5)。对纽约州北部中毒中心和纽约市中毒控制中心报告的洛哌丁胺滥用病例进行了人口统计学、暴露、临床和实验室特征分析。对国家毒物数据库系统(NPDS)报告的故意滥用洛哌丁胺病例也进行了人口统计学、剂量、剂型和结果信息分析。